ABUS—This dual-nuc trial was announced back in June (#msg-164648753), so it took six months to dose the first patient. I continue to question the merit of using two nucs and think that ABUS is flailing.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”